论文部分内容阅读
目的:本研究旨在比较多西紫杉醇+表柔比星与多西紫杉醇+卡培他滨作为一线方案治疗中晚期乳腺癌(ABC)的疗效。
Purpose: This study was designed to compare the efficacy of docetaxel + epirubicin plus docetaxel plus capecitabine in the treatment of advanced breast cancer (ABC) as a first-line regimen.